These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25108027)

  • 1. Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants.
    Tchakoute CT; Hesseling AC; Kidzeru EB; Gamieldien H; Passmore JA; Jones CE; Gray CM; Sodora DL; Jaspan HB
    J Infect Dis; 2015 Feb; 211(3):338-46. PubMed ID: 25108027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial.
    Gasper MA; Hesseling AC; Mohar I; Myer L; Azenkot T; Passmore JS; Hanekom W; Cotton MF; Crispe IN; Sodora DL; Jaspan HB
    JCI Insight; 2017 Apr; 2(7):e91963. PubMed ID: 28405623
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial.
    Nemes E; Hesseling AC; Tameris M; Mauff K; Downing K; Mulenga H; Rose P; van der Zalm M; Mbaba S; Van As D; Hanekom WA; Walzl G; Scriba TJ; McShane H; Hatherill M;
    Clin Infect Dis; 2018 Feb; 66(4):554-563. PubMed ID: 29028973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed BCG vaccination results in minimal alterations in T cell immunogenicity of acellular pertussis and tetanus immunizations in HIV-exposed infants.
    Blakney AK; Tchakoute CT; Hesseling AC; Kidzeru EB; Jones CE; Passmore JA; Sodora DL; Gray CM; Jaspan HB
    Vaccine; 2015 Sep; 33(38):4782-9. PubMed ID: 26259542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination.
    Jones CE; Hesseling AC; Tena-Coki NG; Scriba TJ; Chegou NN; Kidd M; Wilkinson RJ; Kampmann B
    AIDS; 2015 Jan; 29(2):155-65. PubMed ID: 25535752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response.
    Kagina BM; Abel B; Bowmaker M; Scriba TJ; Gelderbloem S; Smit E; Erasmus M; Nene N; Walzl G; Black G; Hussey GD; Hesseling AC; Hanekom WA
    Vaccine; 2009 Sep; 27(40):5488-95. PubMed ID: 19616494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants.
    Lutwama F; Kagina BM; Wajja A; Waiswa F; Mansoor N; Kirimunda S; Hughes EJ; Kiwanuka N; Joloba ML; Musoke P; Scriba TJ; Mayanja-Kizza H; Day CL; Hanekom WA
    J Infect Dis; 2014 Mar; 209(6):887-97. PubMed ID: 24179111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
    Churchyard GJ; Snowden MA; Hokey D; Dheenadhayalan V; McClain JB; Douoguih M; Pau MG; Sadoff J; Landry B
    Vaccine; 2015 Apr; 33(15):1890-6. PubMed ID: 25698492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.
    Hesseling AC; Jaspan HB; Black GF; Nene N; Walzl G
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):454-62. PubMed ID: 25860002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.
    Mansoor N; Scriba TJ; de Kock M; Tameris M; Abel B; Keyser A; Little F; Soares A; Gelderbloem S; Mlenjeni S; Denation L; Hawkridge A; Boom WH; Kaplan G; Hussey GD; Hanekom WA
    J Infect Dis; 2009 Apr; 199(7):982-90. PubMed ID: 19236280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants.
    Miles DJ; Gadama L; Gumbi A; Nyalo F; Makanani B; Heyderman RS
    Immunology; 2010 Mar; 129(3):446-54. PubMed ID: 20002789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV.
    Warr AJ; Anterasian C; Shah JA; De Rosa SC; Nguyen FK; Maleche-Obimbo E; Cranmer LM; Matemo D; Mecha J; Kinuthia J; LaCourse SM; John-Stewart GC; Hawn TR
    EBioMedicine; 2022 Jun; 80():104023. PubMed ID: 35533496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
    Tameris M; Mearns H; Penn-Nicholson A; Gregg Y; Bilek N; Mabwe S; Geldenhuys H; Shenje J; Luabeya AKK; Murillo I; Doce J; Aguilo N; Marinova D; Puentes E; Rodríguez E; Gonzalo-Asensio J; Fritzell B; Thole J; Martin C; Scriba TJ; Hatherill M;
    Lancet Respir Med; 2019 Sep; 7(9):757-770. PubMed ID: 31416768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
    Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
    Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants.
    Mazzola TN; da Silva MT; Abramczuk BM; Moreno YM; Lima SC; Zorzeto TQ; Passeto AS; Vilela MM
    AIDS; 2011 Nov; 25(17):2079-87. PubMed ID: 21866040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses.
    Kagina BM; Tameris MD; Geldenhuys H; Hatherill M; Abel B; Hussey GD; Scriba TJ; Mahomed H; Sadoff JC; Hanekom WA; ; Mansoor N; Hughes J; de Kock M; Whatney W; Africa H; Krohn C; Veldsman A; Kany AL; Douoguih M; Pau MG; Hendriks J; McClainc B; Benko J; Snowden MA; Hokey DA
    Vaccine; 2014 Oct; 32(45):5908-17. PubMed ID: 25218194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants.
    Kidzeru EB; Hesseling AC; Passmore JA; Myer L; Gamieldien H; Tchakoute CT; Gray CM; Sodora DL; Jaspan HB
    AIDS; 2014 Jun; 28(10):1421-30. PubMed ID: 24785950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
    Scriba TJ; Tameris M; Mansoor N; Smit E; van der Merwe L; Mauff K; Hughes EJ; Moyo S; Brittain N; Lawrie A; Mulenga H; de Kock M; Gelderbloem S; Veldsman A; Hatherill M; Geldenhuys H; Hill AV; Hussey GD; Mahomed H; Hanekom WA; McShane H
    J Infect Dis; 2011 Jun; 203(12):1832-43. PubMed ID: 21606542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed BCG vaccination--time to take a shot.
    Kay AW; Blish CA
    J Infect Dis; 2015 Feb; 211(3):335-7. PubMed ID: 25108029
    [No Abstract]   [Full Text] [Related]  

  • 20. The contribution of non-conventional T cells and NK cells in the mycobacterial-specific IFNγ response in Bacille Calmette-Guérin (BCG)-immunized infants.
    Zufferey C; Germano S; Dutta B; Ritz N; Curtis N
    PLoS One; 2013; 8(10):e77334. PubMed ID: 24098583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.